WE ARE
A pharmaceutical company specialized in high quality
ONCOLOGY PRODUCTS
We are a pharmaceutical company specialized in high-quality oncology products in the Middle East. Actero is the result of the joint venture between Actoverco (the Iranian leading pharmaceutical company) and a renowned multinational company currently present in 120 countries.




We are building a unique range of products to cover the needs of cancer patients. Actero is not only focused on chemotherapy, but understands cancer treatment as a whole. That is why we invest in high-quality oncology drugs, as well as in palliative care. All across our portfolio, every Actero medicine stands for reliability.
November 3, 2026
Actover Group Promotes Breast Cancer Awareness
According to Actover Group’s Public Relations Department, the event brought together participants, physicians and pharmacists from across the Group to highlight the importance of early detection and timely treatment of breast cancer. Attendees also received information about breast cancer risk factors, warning signs, self-examination and diagnostic methods.
/
May 1, 2025
Labor Day Tribute from Actoverco
International Labor Day is a global tribute to the unwavering will and tireless hands that shape the future. It is a meaningful occasion to honor those whose dedication, expertise, and commitment drive the engines of progress and prosperity.
/
March 11, 2025
Actero, Sponsor of the 9th International Radio-Oncology Congress
From January 30 to February 1, the 9th International Radio-Oncology Congress was held with the aim of advancing scientific programs in the community and supporting the expansion of cancer research.
/
Find Your Product
With our products, we contribute to the health of people and plants. Here you find an overview of the major Acteropharma products.
A
Z
We understand that pharmaceutical industry is not comparable to other industries. That is why ethical behavior is at the heart of our business.